Company / Operating Cash Flow per Share
Twist Bioscience Corp Operating Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.80
FY2025
5-year range
-$2.50 / -$0.80
FY2021-FY2025
Trend
+27.9%
vs FY2024
Sector context
#105 of 210
Health Care
What the data says
At $-0.80, Twist Bioscience Corp's operating cash flow per share ranks #105 of 210 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 9 years, ranging from $-23689.22 in FY2018 to $-0.02 in FY2017.
Based on SEC 10-K filings.
-0.80 in FY2025.
Improved from $-2.50 to $-0.80 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#105 of 210 in Health CareTop 50% of 210This company -$0.80 Sector average $5.30
▼
-115.0% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 27.9% year-over-year.
- Ranks #105 out of 210 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2017.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.80 | +27.9% |
| FY2024 | -$1.10 | +55.9% |
| FY2023 | -$2.50 | -8.5% |
| FY2022 | -$2.31 | +0.8% |
| FY2021 | -$2.33 | +35.9% |
| FY2020 | -$3.63 | -13.4% |
| FY2019 | -$3.20 | +100.0% |
| FY2018 | -$23689.22 | -111851627.5% |
| FY2017 | -$0.02 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026